HDAC9 and breast cancer: In BC, a tumor specific variant of CPT1 (CPT1A) that lost its ability of fatty acyl transport to the mitochondria promotes survival, resistance to apoptosis and invasion by a mechanism dependent on the increasing activity of HDAC in BC cells [57].